Compare Stryker Corporation (SYK) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Thomson Reuters Corp — how do they compare? Stryker Corporation trades at $277.25 (market cap $106.03B), while Thomson Reuters Corp trades at $97.15 (market cap $42.75B). The key difference: Stryker Corporation is far larger — about 2.5× Thomson Reuters Corp's market cap, and Thomson Reuters Corp pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| SYK | TRI | |
|---|---|---|
Market Cap | $106.03B | $42.75B |
Sector | Technology | Industrials |
52-Week High | $392.76 | $175.65 |
52-Week Low | $276.43 | $76.55 |
Enterprise Value | $117.50B | $45.37B |
Dividend Yield | 1.27% | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals with a P/E of 31.41 and net income margin of 14.43%. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1 2026, while strategic moves like the ZuriMED acquisition and FDA-cleared Apple Vision Pro app highlight innovation. Cash flow improved in 2026, with net cash flow rising to $1.0B from $359M in 2025.
The outlook is positive due to analyst consensus favoring buy ratings (72.55%) and a $376 price target, though risks include competitive pressures and market volatility. Upside potential hinges on execution of growth initiatives, while downside may stem from economic headwinds.
Thomson Reuters (TRI) trades at $98.81, down 6.5% over 24 hours but maintains strong fundamentals with 21.22% net margins and 13.97% ROE. The stock shows bullish technical signals with support at $99 and resistance at $109, while recent Q2 earnings beat expectations with $0.99 EPS versus $0.96 estimates. AI expansion initiatives and recurring revenue growth (82% of total) support momentum, though a recent cybersecurity incident involving court case management systems presents operational risks.
Outlook remains positive with analyst consensus at $104.50 (51.85% buy ratings), driven by organic revenue growth and cost-efficient AI model development. Key risks include cybersecurity vulnerabilities and potential margin pressure from increased technology investments. The current valuation at 27.84 P/E appears reasonable given sustained profitability and market leadership in legal and tax content services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
